ArticleLiver cancer2024

A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.

Shukui Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.